Reasons for Underuse of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer

Elderly patients with stage III CC frequently received either no AC or capecitabine monotherapy because of advanced age and comorbidities. The effect of AC on survival was similar across age groups, with comparable side effects and rates of treatment modifications. AC should not be withheld because of advanced age alone.